CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma

Abstract Background Renal cell carcinoma (RCC) is the most common kidney cancer, accounting for approximately 80–90% of all primary kidney cancer. Treatment for patients with advanced RCC remains unsatisfactory. Rare cancer stem cells (CSCs) are proposed to be responsible for failure of current trea...

Full description

Bibliographic Details
Main Authors: Du-Chu Chen, You-De Liang, Liang Peng, Yi-Ze Wang, Chun-Zhi Ai, Xin-Xing Zhu, Ya-Wei Yan, Yasmeen Saeed, Bin Yu, Jingying Huang, Yuxin Gao, Jiaqi Liu, Yi-Zhou Jiang, Min Liu, Demeng Chen
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-017-0473-z
_version_ 1819060003360735232
author Du-Chu Chen
You-De Liang
Liang Peng
Yi-Ze Wang
Chun-Zhi Ai
Xin-Xing Zhu
Ya-Wei Yan
Yasmeen Saeed
Bin Yu
Jingying Huang
Yuxin Gao
Jiaqi Liu
Yi-Zhou Jiang
Min Liu
Demeng Chen
author_facet Du-Chu Chen
You-De Liang
Liang Peng
Yi-Ze Wang
Chun-Zhi Ai
Xin-Xing Zhu
Ya-Wei Yan
Yasmeen Saeed
Bin Yu
Jingying Huang
Yuxin Gao
Jiaqi Liu
Yi-Zhou Jiang
Min Liu
Demeng Chen
author_sort Du-Chu Chen
collection DOAJ
description Abstract Background Renal cell carcinoma (RCC) is the most common kidney cancer, accounting for approximately 80–90% of all primary kidney cancer. Treatment for patients with advanced RCC remains unsatisfactory. Rare cancer stem cells (CSCs) are proposed to be responsible for failure of current treatment. Methods OncoLnc was used as a tool for interactively exploring survival correlations. Gene manipulation and expression analysis were carried out using siRNA, RT-PCR and Western blotting. Wound healing and invasion assays were used for phenotypical characterization. Aldefluor assay and FACS sorting Sphere culture were used to determine the “stemness” of CSCs. Co-Immunoprecipitation (Co-IP) was used to examine the interaction between OCT4 and CBFA2T2. Student’s t-test and Chi square test was used to analyze statistical significance. Results CBFA2T2 expression can significantly predict the survival of RCC patients. Knocking-down of CBFA2T2 can inhibit cell migration and invasion in RCC cells in vitro, and reduce ALDHhigh CSCs populations. CBFA2T2 expression is necessary for sphere-forming ability and cancer stem cells marker expression in RCC cell lines. Conclusions Our data suggest that CBFA2T2 expression correlates with aggressive characteristics of RCC and CBFA2T2 is required for maintenance of “stemness” through regulation of stem cells factors, thereby highlighting CBFA2T2 as a potential therapeutic target for RCC treatment.
first_indexed 2024-12-21T14:20:05Z
format Article
id doaj.art-33812fac17d545589e9e0983f74a9930
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-21T14:20:05Z
publishDate 2017-11-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-33812fac17d545589e9e0983f74a99302022-12-21T19:00:49ZengBMCCancer Cell International1475-28672017-11-011711810.1186/s12935-017-0473-zCBFA2T2 is associated with a cancer stem cell state in renal cell carcinomaDu-Chu Chen0You-De Liang1Liang Peng2Yi-Ze Wang3Chun-Zhi Ai4Xin-Xing Zhu5Ya-Wei Yan6Yasmeen Saeed7Bin Yu8Jingying Huang9Yuxin Gao10Jiaqi Liu11Yi-Zhou Jiang12Min Liu13Demeng Chen14State Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen UniversityDepartment of Stomatology, Nanshan Affiliated Hospital of Guangdong Medical CollegeDepartment of Oncology, Chinese PLA General HospitalInstitute for Advanced Study, Shenzhen UniversityInstitute for Advanced Study, Shenzhen UniversityInstitute for Advanced Study, Shenzhen UniversityInstitute for Advanced Study, Shenzhen UniversityInstitute for Advanced Study, Shenzhen UniversityState Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen UniversityState Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen UniversityState Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen UniversityState Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen UniversityInstitute for Advanced Study, Shenzhen UniversityState Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen UniversityThe First Affiliated Hospital of Sun Yat-Sen UniversityAbstract Background Renal cell carcinoma (RCC) is the most common kidney cancer, accounting for approximately 80–90% of all primary kidney cancer. Treatment for patients with advanced RCC remains unsatisfactory. Rare cancer stem cells (CSCs) are proposed to be responsible for failure of current treatment. Methods OncoLnc was used as a tool for interactively exploring survival correlations. Gene manipulation and expression analysis were carried out using siRNA, RT-PCR and Western blotting. Wound healing and invasion assays were used for phenotypical characterization. Aldefluor assay and FACS sorting Sphere culture were used to determine the “stemness” of CSCs. Co-Immunoprecipitation (Co-IP) was used to examine the interaction between OCT4 and CBFA2T2. Student’s t-test and Chi square test was used to analyze statistical significance. Results CBFA2T2 expression can significantly predict the survival of RCC patients. Knocking-down of CBFA2T2 can inhibit cell migration and invasion in RCC cells in vitro, and reduce ALDHhigh CSCs populations. CBFA2T2 expression is necessary for sphere-forming ability and cancer stem cells marker expression in RCC cell lines. Conclusions Our data suggest that CBFA2T2 expression correlates with aggressive characteristics of RCC and CBFA2T2 is required for maintenance of “stemness” through regulation of stem cells factors, thereby highlighting CBFA2T2 as a potential therapeutic target for RCC treatment.http://link.springer.com/article/10.1186/s12935-017-0473-zCBFA2T2Renal cell carcinomaCancer stem cellsOCT-4NANOG
spellingShingle Du-Chu Chen
You-De Liang
Liang Peng
Yi-Ze Wang
Chun-Zhi Ai
Xin-Xing Zhu
Ya-Wei Yan
Yasmeen Saeed
Bin Yu
Jingying Huang
Yuxin Gao
Jiaqi Liu
Yi-Zhou Jiang
Min Liu
Demeng Chen
CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma
Cancer Cell International
CBFA2T2
Renal cell carcinoma
Cancer stem cells
OCT-4
NANOG
title CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma
title_full CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma
title_fullStr CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma
title_full_unstemmed CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma
title_short CBFA2T2 is associated with a cancer stem cell state in renal cell carcinoma
title_sort cbfa2t2 is associated with a cancer stem cell state in renal cell carcinoma
topic CBFA2T2
Renal cell carcinoma
Cancer stem cells
OCT-4
NANOG
url http://link.springer.com/article/10.1186/s12935-017-0473-z
work_keys_str_mv AT duchuchen cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT youdeliang cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT liangpeng cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT yizewang cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT chunzhiai cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT xinxingzhu cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT yaweiyan cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT yasmeensaeed cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT binyu cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT jingyinghuang cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT yuxingao cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT jiaqiliu cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT yizhoujiang cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT minliu cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma
AT demengchen cbfa2t2isassociatedwithacancerstemcellstateinrenalcellcarcinoma